Cartesian Therapeutics, Inc. (RNAC) — Dilution Risk Analysis
Current Snapshot
Cartesian Therapeutics, Inc. (RNAC) has a DilutionWatch score of 33/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 33/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: XBRL 1, 4 9.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-4987-xbrl_warrant |
| 4 | 2026-04-06 | 0002064832-26-000148 |
| 4 | 2026-04-06 | 0002064832-26-000149 |
| 4 | 2026-03-13 | 0001453687-26-000066 |
| 4 | 2026-01-08 | 0001453687-26-000045 |
| 4 | 2026-01-08 | 0001453687-26-000046 |
| 4 | 2026-01-08 | 0001453687-26-000047 |
| 4 | 2026-01-06 | 0001453687-26-000028 |
| 4 | 2026-01-06 | 0001453687-26-000029 |
| 4 | 2026-01-06 | 0001453687-26-000030 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 27 months | Source |
| Three-year share count growth | 55.95% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 33/10) Source
- Cash Runway
- 27 months Source
- Share Count Growth (3-Year)
- 55.95% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.